HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weizhe Xu Selected Research

Hepatocellular Carcinoma (Hepatoma)

10/2022Oncolytic Vaccinia Virus Carrying Aphrocallistes vastus Lectin (oncoVV-AVL) Enhances Inflammatory Response in Hepatocellular Carcinoma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Weizhe Xu Research Topics

Disease

4Inflammation (Inflammations)
10/2022 - 01/2018
3Neoplasms (Cancer)
11/2023 - 01/2022
1Chronobiology Disorders (Circadian Rhythm Disorder)
05/2023
1Non-alcoholic Fatty Liver Disease
12/2022
1Prostatic Neoplasms (Prostate Cancer)
12/2022
1Hepatocellular Carcinoma (Hepatoma)
10/2022
1Pulpitis
10/2022
1Periodontitis
01/2020
1Wounds and Injuries (Trauma)
01/2020
1Mycoplasma Infections
02/2017
1Infections
02/2017
1Depressive Disorder (Melancholia)
01/2016

Drug/Important Bio-Agent (IBA)

1Metal-Organic FrameworksIBA
11/2023
1MelatoninIBA
05/2023
1Hormones (Hormone)IBA
05/2023
1Hydrocortisone (Cortisol)FDA LinkGeneric
05/2023
1Nonesterified Fatty Acids (NEFA)IBA
12/2022
1EPI 001IBA
12/2022
1SugarsIBA
12/2022
1Androgen Receptors (Androgen Receptor)IBA
12/2022
1LectinsIBA
10/2022
1Type II Tumor Necrosis Factor ReceptorsIBA
10/2022
1LigandsIBA
06/2022
1CateninsIBA
01/2020
1Virulence Factors (Pathogenicity Factors)IBA
01/2020
1NucleotidesIBA
12/2019
1Acetylmuramyl-Alanyl-IsoglutamineIBA
12/2019
1Advanced Glycation End ProductsIBA
12/2019
1Interleukin-12 (IL 12)IBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1RoxithromycinIBA
02/2017
1Anti-Bacterial Agents (Antibiotics)IBA
02/2017
1MacrolidesIBA
02/2017
1albiflorinIBA
01/2016

Therapy/Procedure

3Therapeutics
11/2023 - 10/2022
1Immunotherapy
01/2022